Zhang Haifeng, Gao Na, Tian Xin, Liu Tingting, Fang Yan, Zhou Jun, Wen Qiang, Xu Binbin, Qi Bing, Gao Jie, Li Hongmeng, Jia Linjing, Qiao Hailing
Institute of Clinical Pharmacology, Zhengzhou University, Zhengzhou, China.
Sci Rep. 2015 Dec 4;5:17671. doi: 10.1038/srep17671.
The lack of information concerning individual variation in content and activity of human liver microsomal protein is one of the most important obstacles for designing personalized medicines. We demonstrated that the mean value of microsomal protein per gram of liver (MPPGL) was 39.46 mg/g in 128 human livers and up to 19-fold individual variations existed. Meanwhile, the metabolic activities of 10 cytochrome P450 (CYPs) were detected in microsomes and liver tissues, respectively, which showed huge individual variations (200-fold). Compared with microsomes, the activities of liver tissues were much suitable to express the individual variations of CYP activities. Furthermore, individual variations in the in vivo clearance of tolbutamide were successfully predicted with the individual parameter values. In conclusion, we offer the values for MPPGL contents in normal liver tissues and build a new method to assess the in vitro CYP activities. In addition, large individual variations exist in predicted hepatic clearance of tolbutamide. These findings provide important physiological parameters for physiologically-based pharmacokinetics models and thus, establish a solid foundation for future development of personalized medicines.
缺乏关于人肝微粒体蛋白含量和活性个体差异的信息是设计个性化药物的最重要障碍之一。我们证明,128例人肝脏中每克肝脏微粒体蛋白(MPPGL)的平均值为39.46 mg/g,个体差异高达19倍。同时,分别在微粒体和肝组织中检测了10种细胞色素P450(CYPs)的代谢活性,结果显示出巨大的个体差异(200倍)。与微粒体相比,肝组织的活性更适合表达CYP活性的个体差异。此外,利用个体参数值成功预测了甲苯磺丁脲的体内清除率个体差异。总之,我们提供了正常肝组织中MPPGL含量的值,并建立了一种评估体外CYP活性的新方法。此外,甲苯磺丁脲的预测肝清除率存在较大个体差异。这些发现为基于生理学的药代动力学模型提供了重要的生理参数,从而为个性化药物的未来发展奠定了坚实基础。